Red blood cells are designed to pick up oxygen in the lungs and transport it throughout the body via the circulatory system. Their donut-like shape and water-balloon-like flexibility allows them to pass through even the tiniest blood vessels.
Sickle cell anemia is a hereditary condition that causes some red blood cells to distort into rigid crescent moon shapes, and take on a consistency like cream cheese when oxygen is released. The affected cells can clog up blood vessels preventing adequate blood flow. Sickled cells also have a shorter life span than their healthy counterparts. Fewer red blood cells means less oxygen is delivered to organs and tissues in the body. Some individuals with sickle cell anemia experience only mild symptoms, but others can suffer severe consequences.
Normal red blood cells can flow freely through blood vessels. Sickled cells get stuck in the blood vessels and cause blockages.
Anemia
Because individuals with sickle cell anemia do not have enough oxygen-carrying
red blood cells, their bodies do not get an adequate oxygen supply. They
can become easily fatigued and experience shortness of breath. Often their
skin and fingernails are pale. Taking folic acid can help the body to produce
more red blood cells, but anemia is often a chronic part of living with sickle
cell anemia. In extreme cases, patients are given blood transfusions.
Poor Circulation
Because sickled cells restrict blood flow, individuals can periodically experience
swelling and extreme pain in any body organ or joint. This can last for hours
or weeks. Sometimes permanent damage can occur to organs deprived of oxygen
and nutrients. Keeping warm and drinking lots of fluids helps to improve
circulation. During acute episodes, some patients take painkilling drugs
and are provided with intravenous fluids to minimize damage.
Infection
Individuals suffering from sickle cell anemia are more vulnerable to infection
because over time, their spleens become damaged from the lack of oxygen and
nutrients. The spleen usually works to destroy the bacteria that can cause
infections. If the spleen is damaged, it is no longer able to perform this
task. Children with sickle cell anemia are often given penicillin on a regular
basis to help prevent infection.
Cause for Hope
Although there is currently no cure for sickle cell anemia, there have been
encouraging advances in treatment. Hydroxyurea is the first drug that the
Food and Drug Administration has approved for the treatment of sickle cell
anemia and provides dramatic results. When administered over time, it halves
the number of painful episodes experienced by patients. Hydroxyurea also
prolongs the lives of the sickest patients. Researchers are planning studies
to see how hydroxyurea can help treat children.
Gene Mutation
Sickle cell anemia is an inherited disease caused by a mutation in the gene
that tells the body how to make hemoglobin, the molecule within red blood
cells that collects oxygen. Each person has two genes that give hemoglobin
instructions—one from each parent. If individuals have one gene that
produces normal hemoglobin and one gene that produces abnormal sickle cell
hemoglobin, they have sickle cell trait. They will not suffer from the disease,
but may pass on the abnormal gene to their children. If individuals have
two genes that produce the abnormal hemoglobin, they will have sickle cell
anemia.
Determine the Risk
People who are planning to become parents can find out whether they are carriers
of the sickle cell gene. A simple blood test can provide the answers. View
the parent combination and select the child’s risk of inheriting sickle
cell anemia and sickle cell trait.
Dr. Marilyn Hughes Gaston first encountered sickle cell anemia while interning
at Philadelphia General Hospital. A baby with a badly swollen hand was admitted
to her care. Dr. Gaston was unable to find the cause until her supervising
resident suggested sickle cell anemia. The baby tested positive for the disease.
His hand was swollen with a serious infection caused by lack of blood flow
to the area. Dr. Gaston decided to focus on sickle cell disease. In 1986 she
concluded a groundbreaking study proving that providing long-term penicillin
treatment to children with sickle cell anemia helped to prevent infections.